Minimally symptomatic infection in an Ebola ‘hotspot’: A cross-sectional serosurvey
Minimally symptomatic infection in an Ebola ‘hotspot’: A cross-sectional serosurvey
Evidence for minimally symptomatic Ebola virus (EBOV) infection is limited. During the 2013–16 outbreak in West Africa, it was not considered epidemiologically relevant to published models or projections of intervention effects. In order to improve our understanding of the transmission dynamics of EBOV in humans, we investigated the occurrence of minimally symptomatic EBOV infection in quarantined contacts of reported Ebola virus disease cases in a recognized ‘hotspot.’
Publication Date:
15/11/2016
1-10